MedTrace Logo

Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms

NCT07485036 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-11

No results posted yet for this study

Summary

This study aims to learn about depression and alcohol use in postpartum mothers and whether an intervention based on contingency management and problem-solving therapy (CM-PST) can help reduce these symptoms. The main questions it seeks to answer are:

1. How do new mothers fare with depressive symptoms and alcohol use in the first 12 months after giving birth?
2. Will a CM-PST intervention reduce depressive symptoms and alcohol use frequency among new mothers?
3. Is a CM-PST intervention practical for new mothers?

The researchers will recruit approximately 30 new mothers and randomly select half to attend a 6-week CM-PST intervention. They will compare those who received the intervention versus those who did not to see if there are any differences in their depressive symptoms and alcohol usage.

Participants will:

* Complete 4 remote intervention sessions over 6 weeks
* Conduct at-home urine drug tests 2x per week during the 6-week intervention
* Answer online surveys about their mental health and alcohol use

Conditions

  • Postpartum Depression (PPD)
  • Alcohol Use
  • Contingency Management
  • Problem Solving Therapy

Interventions

BEHAVIORAL

Contingency Management & Problem Solving Therapy

A 6-week online CM-PST course delivered through video conferencing calls consisting of 4 educational sessions, combined with 2x weekly at-home drug testing to monitor the reduction in alcohol use and reduced depression symptoms.

OTHER

Usual Care

Participants randomized to the usual care condition will continue to receive standard postpartum care from their obstetrician-gynecologist, consistent with routine clinical practice. No additional psychological intervention will be provided as part of the study.

Sponsors & Collaborators

  • University of Illinois at Chicago

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-05-30
Completion
2027-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07485036 on ClinicalTrials.gov